Literature DB >> 4088313

Second cancer following cancer of the digestive system in Connecticut, 1935-82.

S K Hoar, J Wilson, W J Blot, J K McLaughlin, D M Winn, A F Kantor.   

Abstract

The risk of developing a second primary cancer was evaluated in approximately 64,000 persons diagnosed with cancer of the digestive system in Connecticut during 1935-82. Significant excesses of all second cancers combined were observed following cancer of the esophagus (58 observed vs. 33 expected), small intestine (41 vs. 24), and colon (2,268 vs. 1,714). A slight excess of multiple primaries was observed following cancer of the liver and biliary tract (47 vs. 40). The observed number of second cancers was nearly equal to the expected number for persons initially diagnosed with cancers of the stomach (251 vs. 258), rectum (952 vs. 941), and pancreas (40 vs. 40). Persons with initial cancers of the small intestine, colon, and rectum also had excess second cancers arising primarily in the colon, which suggested the influence of common etiologic factors or possibly misclassified metastases in some. Shared dietary, socioeconomic, or hormonal factors may explain the excess of uterine and ovarian cancers among patients with colon cancer and the excess of breast cancer among patients with colon and rectal cancers. Oral and respiratory cancers occurred more frequently than expected in persons with an initial esophageal cancer, which is likely due to common risk factors of cigarette smoking or alcohol intake, or both. The elevations in cancer of the prostate among males with cancers of the esophagus, small intestine, colon, rectum, liver/biliary, and pancreas are probably artifacts associated with increased medical surveillance of cancer patients. The prostate cancer excesses were limited to the first year after diagnosis of the initial cancer or decreased over time for all but cancer of the colon and small intestines. Increased medical surveillance may also contribute to the excess renal and bladder cancers seen within 5 years of diagnosis of stomach cancer. Excesses were also seen for second pancreatic cancer among small intestine and liver/biliary cancer patients and second kidney and brain cancers among those with colon cancer. The deficits of stomach and rectal cancer among persons initially diagnosed with the same tumors, respectively, were anticipated because surgical removal of the organ is the primary form of treatment. Patients with rectal cancer also had deficits of stomach and pancreatic cancers. Future research should clarify the role of diet, alcohol, metabolic and endocrine factors, and host susceptibility on the risk of second neoplasms following cancer of the digestive system.

Entities:  

Mesh:

Year:  1985        PMID: 4088313

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  12 in total

1.  Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Authors:  Todd M Gibson; Yikyung Park; Kim Robien; Meredith S Shiels; Amanda Black; Joshua N Sampson; Mark P Purdue; Laura E Beane Freeman; Gabriella Andreotti; Stephanie J Weinstein; Demetrius Albanes; Joseph F Fraumeni; Rochelle E Curtis; Amy Berrington de Gonzalez; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

2.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.

Authors:  Aung Ko Win; Noralane M Lindor; Joanne P Young; Finlay A Macrae; Graeme P Young; Elizabeth Williamson; Susan Parry; Jack Goldblatt; Lara Lipton; Ingrid Winship; Barbara Leggett; Katherine M Tucker; Graham G Giles; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Julie Arnold; A Joan Levine; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; John L Hopper; Mark A Jenkins
Journal:  J Natl Cancer Inst       Date:  2012-08-28       Impact factor: 13.506

Review 3.  Second malignancies among elderly survivors of cancer.

Authors:  Ari M VanderWalde; Arti Hurria
Journal:  Oncologist       Date:  2011-10-31

4.  Increased cumulative incidence of prostate malignancies in colorectal cancer patients.

Authors:  Nuri Ozden; Murat Saruc; Lynette M Smith; Arthi Sanjeevi; Hemant K Roy
Journal:  Int J Gastrointest Cancer       Date:  2003

5.  Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study.

Authors:  Gemma Gatta; Laura Ciccolallo; Jean Faivre; Anne-Marie Bouvier; Franco Berrino; Jean Pierre Gerard
Journal:  J Cancer Surviv       Date:  2007-09-27       Impact factor: 4.442

6.  Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

Authors:  C S Cropp; R Lidereau; G Campbell; M H Champene; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Subsequent primary cancers in relation to treatment of ovarian cancer.

Authors:  P Prior; D J Pope
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

8.  Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer.

Authors:  Joo Won Chung; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Si Young Song; Jae Bock Chung; Jeong Youp Park
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

9.  Secondary Primary Prostate Cancer after Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea.

Authors:  Hyun Soo Kim; Yoon Jin Choi; Dong Woo Shin; Kyung-Do Han; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  J Cancer Prev       Date:  2017-12-30

10.  Multiple primary cancers in Connecticut, 1935-82.

Authors:  J D Boice; R E Curtis; R A Kleinerman; J T Flannery; J F Fraumeni
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.